This book chronicles the rise of Glaxo, the world's second-largest pharmaceutical multinational, from its inception to 1962. Based on unprecedented access to company archives, the study details Glaxo's global operations, tracing the evolution of its international business, research and development programs, product lines, and marketing and management strategies. It presents a comprehensive examination of a UK-based drugs company, exploring themes of power, money, and pharmaceuticals.

This comprehensive study of Glaxo, drawing on unparalleled archival access, offers a detailed account of the company's global operations and business evolution up to 1962. The book is recognized for its in-depth analysis of the pharmaceutical industry, covering research, development, products, marketing, and management. It is considered the first such detailed study of a UK-based drugs company, exploring significant themes within its history.